Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
min decrease » mean decrease (Expand Search), point decrease (Expand Search), gain decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
min decrease » mean decrease (Expand Search), point decrease (Expand Search), gain decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
141
Average measures of PPLK, PMC, PHS and other short-term quantitative precipitation nowcasting (QPN) methods with 30 min, 60 min, 90 min and 120 min lead time.
Published 2015“…</p><p>Average measures of PPLK, PMC, PHS and other short-term quantitative precipitation nowcasting (QPN) methods with 30 min, 60 min, 90 min and 120 min lead time.</p>…”
-
142
-
143
-
144
-
145
Time spent sedentary and active during baseline and the 3 physical activity break conditions.
Published 2014Subjects: -
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression.
Published 2019“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A<sub>165</sub>b relative to total VEGF-A<sub>165</sub> (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A<sub>165</sub>b before stripping and reprobing with panVEGF-A). …”
-
156
-
157
-
158
-
159
-
160